| Trial ID: | L5827 |
| Source ID: | NCT06125587
|
| Associated Drug: |
Chiglitazar
|
| Title: |
Chiglitazar/Metformin in Non-obese Women With PCOS
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Polycystic Ovary Syndrome|Chiglitazar|Metformin
|
| Interventions: |
DRUG: Chiglitazar|DRUG: Metformin
|
| Outcome Measures: |
Primary: Plasma insulin level, Changes in insulin level before and after treatment, Three months | Secondary: Total testosterone, Changes in total testosterone (TT), Three months|Sex hormone-binding globulin, Changes in sex hormone-binding globulin (SHBG), Three months|Ratio of luteinizing hormone to follicular estrogen, Changes in ratio of luteinizing hormone to follicular estrogen (LH/FSH), Three months|BMI and WHtR, Anthropometric indices, including height, weight, waist-to-height ratio (WHtR) and BMI, were assessed at baseline and at 12 weeks after randomization via a standardized protocol., At baseline and at 12 weeks after randomization via a standardized protocol.
|
| Sponsor/Collaborators: |
Sponsor: Shengjing Hospital
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
55
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-11-15
|
| Completion Date: |
2024-11-20
|
| Results First Posted: |
|
| Last Update Posted: |
2025-01-01
|
| Locations: |
Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT06125587
|
